Belgium· BE-AMP-SAM475022-00

Etoposide Accord Healthcare 20 mg/ml

A etoposide product containing etoposide, registered in Belgium by Accord Healthcare. The same ATC class is registered in 17 of our 19 countries.

ATC L01CB01

Checked against FAMHP / AFMPS (Belgium) on September 26, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about etoposideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Etoposide is registered in 17 of 19 countries.

Countries holding a registration under ATC L01CB01 (etoposide), each read from that country’s own register.

This record: Belgium, from FAMHP / AFMPS (Belgium)
10 of them publish a price we can compare per daily dose

Search etoposide products by name

Etoposide · ATC L01CB01

17 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of etoposide costs, country by country.

Normalised to the WHO defined daily dose (50 mg), the median price runs from $9.95 in France to $18.65 in Switzerland — a ×1.9 gap.

2 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Etoposide · price per daily dose (50 mg)

USD · FX 28 Sept 2026

CH Switzerland$18.65
FR France$9.95

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)

Active substance: Etoposide
Manufacturer: Accord Healthcare
Country: Belgium (BE)
ATC code: L01CB01
ATC class: Etoposide
Defined daily dose: 50 mg, O
Reimbursed: Not published by this register
Source register: FAMHP / AFMPS (Belgium)
Last checked: September 26, 2026

Packs & prices · 2

be_apb
7739279
be_apb
4776019

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

576 interactions on record for etoposide.

Graded by severity as the source publishes them — 30 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check etoposide against other medicines How interaction checks work

Etoposide · interactions on record

576 records

30 severe
290 moderate
21 minor
235 info

Most severe, free to view

CladribineL01BB04severe
AprepitantA04AD12moderate
RolapitantA04AD14moderate
EliglustatA16AX10moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Etoposide in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All etoposide products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

Austria · Etoposid Accord, Etoposid Ebewe
Bulgaria · Eтопозид Акорд
Cyprus · Etoposide Accord
Czechia · Etoposid Ebewe, Etoposide Accord
Germany · Eto-Cell, Eto-Cell®
Denmark · Etoposid Accord, Etoposid Ebewe
Estonia · Etoposide Accord, Etoposide Kabi
Spain · Etopósido Accord, Etopósido Hikma
Finland · Etoposid Fresenius Kabi, Etoposide Accord
France · Celltop, Etopophos
United Kingdom (Northern Ireland) · Etopophos, Etoposide
Greece · Etobion
Croatia · Etoposide Sandoz
Hungary · Etoposid Sandoz, Etoposide Accord
Ireland · Etoposide, Etoposide Accord Healthcare
Iceland · Etópósíð Accord
Italy · Etoposide Accord, Etoposide Hikma
Lithuania · Etoposid Ebewe, Etoposide Accord
Luxembourg · Eposin, Etoposide Accord Healthcare
Latvia · Etoposide Accord, Etoposide Ebewe
Netherlands · Eposin, Etoposide Accord
Norway · Etoposid Ebewe, Etoposid Fresenius Kabi
Poland · Etoposid Ebewe, Etopozyd Accord
Portugal · Etoposido Accord, Etoposido Hikma
Romania · Etoposid Accord, Etoposide Teva
Sweden · Eposin, Etopofos
Slovenia · Ebeposid, Eposin
Slovakia · Etoposid Sandoz, Etopozid Accord

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/acc010ae-32d1-48ff-83d3-e95fb7d7a64b
GET /v1/drugs/acc010ae-32d1-48ff-83d3-e95fb7d7a64b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Concentrate for solution for infusion",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Etoposide Accord Healthcare 20 mg/ml",
  "name_fr": "Etoposide Accord Healthcare 20 mg/ml",
  "name_nl": "Etoposide Accord Healthcare 20 mg/ml",
  "amp_code": "SAM475022-00",
  "strengths": [
    "20.0000",
    "30.0000",
    "80.0000"
  ],
  "pack_count": 1,
  "substances": [
    "Etoposide",
    "Benzyl Alcohol",
    "Anhydrous Ethanol",
    "Polysorbate 80"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Etoposide",
  "authorisation_numbers": [
    "BE475022"
  ]
}

API reference MCP server Plans

See everything about etoposide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console